Mumps Outbreak in a Highly Vaccinated School Population
- 1 July 1995
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Pediatrics & Adolescent Medicine
- Vol. 149 (7) , 774-778
- https://doi.org/10.1001/archpedi.1995.02170200064010
Abstract
Objectives: To describe an outbreak and to identify risk factors for mumps occurring in a highly vaccinated high school population. (Note: Highly vaccinated means a population in which more than 95% have been vaccinated.) Design and Participants: Survey and cohort study of 307 (97%) of 318 students. Outcome Measures: Mumps was defined as an illness with 2 or more days of parotid swelling. Serologic confirmation of infection was obtained in eight cases, seven of which were evaluated for presence of IgM antibody using immunofluorescent antibodies. Vaccination records were verified for 297 (97%) students. Results: Between October 3 and November 23, 1990, clinical mumps developed in 54 students (attack rate, 18%), 53 of whom had been vaccinated. Most cases (40 [77%] of 52) occurred 12 to 20 days after a school-wide pep rally. Immunofluorescent antibody testing of all seven specimens demonstrated IgM antibody to mumps. Risk factors for clinical mumps identified in multivariate analyses included female gender (odds ratio, 3.0; 95% confidence interval, 1.6 to 5.7) and source of vaccination other than the local public health clinic (students vaccinated by private providers [odds ratio, 3.0; 95% confidence interval, 1.3 to 5.2] or in other districts [odds ratio, 2.4; 95% confidence interval, 1.1 to 5.3]). Conclusions: The overall attack rate is the highest reported to date (and to our knowledge) for a population demonstrating virtually complete mumps vaccine coverage. Even verified documentation of vaccination may not be an accurate indicator of an individual's protection against mumps. Vaccination failure may play an important role in contemporary mumps outbreaks. We found no evidence to indicate that waning immunity (secondary vaccine failure) contributed significantly to this outbreak. A second dose of mumps vaccine, as recommended using measles-mumps-rubella vaccine, could potentially prevent similar outbreaks in secondary school populations in the future. (Arch Pediatr Adolesc Med. 1995;149:774-778)Keywords
This publication has 8 references indexed in Scilit:
- Duration of live measles vaccine-induced immunityThe Pediatric Infectious Disease Journal, 1990
- A Large Outbreak of Mumps in the Postvaccine EraThe Journal of Infectious Diseases, 1988
- Mumps in the workplace. Further evidence of the changing epidemiology of a childhood vaccine-preventable diseaseJAMA, 1988
- Perspectives on the Relative Resurgence of Mumps in the United StatesArchives of Pediatrics & Adolescent Medicine, 1988
- Effectiveness of Mumps Vaccine in a School OutbreakArchives of Pediatrics & Adolescent Medicine, 1985
- Evaluation of a Live Attenuated Mumps Vaccine (Jeryl Lynn)American Journal of Diseases of Children, 1969
- Ineffectiveness of Isolation of Patients as a Method of Preventing the Spread of MumpsNew England Journal of Medicine, 1968
- Field evaluation of live virus mumps vaccineThe Journal of Pediatrics, 1968